GOLDEN ENTERTAINMENT, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GOLDEN ENTERTAINMENT, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $634.91M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $666.82M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.05B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.12B | Apr 25, 2025 |
| FY2015 | Dec 31, 2015 | $185.92M | Mar 14, 2016 |
| FY2015 | Dec 28, 2014 | $58.36M | Mar 14, 2016 |
| FY2015 | Dec 29, 2013 | $39.93M | Mar 14, 2016 |
| FY2014 | Dec 30, 2012 | $10.95M | Mar 12, 2015 |
| FY2012 | Jan 1, 2012 | $35.57M | Mar 15, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.05B | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $1.12B | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $1.10B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $694.16M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $242.13M | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | $243.31M | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | $248.07M | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | $239.89M | Mar 13, 2020 |
| FY2019 | Dec 31, 2018 | $210.13M | Mar 13, 2020 |
| FY2019 | Sep 30, 2018 | $210.34M | Mar 13, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $184.35M | Mar 16, 2018 |
| FY2017 | Sep 30, 2017 | $108.32M | Mar 16, 2018 |
| FY2017 | Jun 30, 2017 | $110.49M | Mar 16, 2018 |
| FY2017 | Mar 31, 2017 | $106.65M | Mar 16, 2018 |
| FY2017 | Dec 31, 2016 | $105.39M | Mar 16, 2018 |
| FY2017 | Sep 30, 2016 | $104.23M | Mar 16, 2018 |
| FY2017 | Jun 30, 2016 | $102.56M | Mar 16, 2018 |
| FY2017 | Mar 31, 2016 | $91.03M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $86.44M | Mar 16, 2017 |
| FY2016 | Sep 30, 2015 | $62.51M | Mar 16, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.04M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $50.73M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $255.76M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $82.35M | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $161.78M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($136.61M) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | ($7.67M) | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | ($9.45M) | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | ($14.41M) | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | ($8.02M) | Mar 13, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.53M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $112.12M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $399.21M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $147.95M | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $166.04M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($67.44M) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $10.50M | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | $9.88M | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | $14.02M | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | $11.71M | Mar 13, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.08B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.45B | Apr 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.51B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.62B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.57B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.74B | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $1.37B | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $1.37B | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $419.08M | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $597.19M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $605.68M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $914.55M | Apr 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.16B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.30B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.41B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.45B | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $1.05B | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $1.05B | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $209.65M | Mar 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $420.90M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $474.23M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $537.73M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $352.92M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $319.54M | Apr 25, 2025 |
| FY2023 | Dec 31, 2020 | $161.26M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $289.74M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $315.15M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $319.91M | Mar 12, 2021 |
| FY2019 | Dec 31, 2016 | $209.43M | Mar 13, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | (4) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 13, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | (4) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 13, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.33M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $57.73M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $157.55M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $136.89M | Apr 25, 2025 |
| FY2023 | Dec 31, 2021 | $220.54M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $103.56M | Mar 1, 2023 |
| FY2020 | Dec 31, 2019 | $111.68M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $116.07M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $90.58M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $46.90M | Mar 16, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $1.14B | Mar 13, 2020 |
| FY2019 | Dec 31, 2018 | $971.04M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $972.96M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $183.44M | Mar 16, 2018 |
| FY2015 | Dec 31, 2015 | $148.64M | Mar 14, 2016 |
| FY2015 | Dec 28, 2014 | $11.74M | Mar 14, 2016 |
| FY2014 | Dec 29, 2013 | $13.50M | Mar 12, 2015 |